New Insights into the Role of Inflammation in the Pathogenesis of Atherosclerosis.

Wu MY, Li CJ, Hou MF, Chu PY. · 2017

Read New Insights into the Role of Inflammation in the Pathogenesis of Atherosclerosis. by Wu MY, Li CJ, Hou MF, Chu PY. (2017) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc5666716.txt.

Introduction

Wu and co-authors present a review in the International Journal of Molecular Sciences. It examines inflammation in the development of atherosclerosis. This disease narrows arteries with lipid-rich plaques. Plaques also show cell growth, cell death, and scarring. Immune responses shape every phase of the process. The review links those responses to the plaque microenvironment.

Early steps start with retained low-density lipoprotein in vessel walls. Oxidation changes that lipoprotein into a trigger for immune cells. Macrophages take it up through scavenger receptors. Oxidative stress from smoking or high blood sugar adds fuel. The authors detail lipid handling and immune activation steps. Their aim is a clearer map for future treatment ideas.

Catalog record

CREATORWu MY, Li CJ, Hou MF, Chu PY.
YEAR2017
COLLECTIONPAPERS
FORMATTXT
FILE SIZE67 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC5666716

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

New Insights into the Role of Inflammation in the Pathogenesis of Atherosclerosis By Meng-Yu Wu, Chia-Jung Li, Ming-Feng Hou, Pei-Yi Chu Published in: International Journal of Molecular Sciences DOI: 10.3390/ijms18102034 ABSTRACT Abstract Atherosclerosis is a chronic inflammatory disease characterized by the accumulation of lipids, smooth muscle cell proliferation, cell apoptosis, necrosis, fibrosis, and local inflammation. Immune and inflammatory responses have significant effects on every phase of atherosclerosis, and increasing evidence shows that immunity plays a more important role in atherosclerosis by tightly regulating its progression. Therefore, understanding the relationship between immune responses and the atherosclerotic microenvironment is extremely important. This article reviews existing knowledge regarding the pathogenesis of immune responses in the atherosclerotic microenvironment, and the immune mechanisms involved in atherosclerosis formation and activation. Keywords: atherosclerosis, atherosclerotic immunity, atherosclerotic microenvironment, oxidative stress, macrophage 1. INTRODUCTION Atherosclerosis is a chronic inflammatory disease characterized by intense immunological activity. Atherosclerosis is widespread, and leads to morbidity and mortality along with the development of circulatory problems, including coronary artery disease and cerebrovascular disease [1]. In the heart, atherosclerosis can cause myocardial infarction and heart failure due to coronary artery stenosis, and in the brain, the stenosis or rupture of atherosclerotic plaques leads to transient ischemic attacks, ischemic stroke, or hemorrhage stroke. If stenosis affects renal arterial branches, it can result in renal impairment and general hypertension. On other arterial branches of extremities, atherosclerosis can lead to peripheral arterial occlusion disease and critical limb ischemia. The formation of atherosclerotic plaques, which are characterized by the accumulation of lipids, local inflammation, smooth muscle cell (SMC) proliferation, cell apoptosis, necrosis, and fibrosis, is a major causative factor of arterial stenosis, and involves a chronic inflammatory response initiated by endothelial damage and inflammatory cell activation [2]. This review article summarizes current knowledge regarding the role of immunity in atherosclerosis and, in particular, the pathogenesis of human atherosclerosis. The atherosclerotic microenvironment and mechanisms associated with immune responses to atherosclerosis are also discussed in detail. 2. LIPID METABOLISM AND LOW-DENSITY LIPOPROTEIN (LDL) MODIFICATION 2.1. Roles of Lipid Metabolism in Atherosclerosis Cholesterol, triglycerides, and lipoproteins are implicated in atherosclerosis pathogenesis. Increased serum low-density lipoprotein (LDL) and triglyceride concentrations are responsible for the formation of atherosclerotic lesions [3]. The roles of lipid metabolism and LDL modification are important for atherosclerosis development. Lipid metabolism occurs via exogenous and endogenous pathways. The exogenous pathway begins with chylomicron synthesis and secretion by the intestine. Chylomicrons contain apolipoproteins (Apos) B-48, C-II, and E. The Apo C-II is an essential cofactor of lipoprotein lipase (LPL) transport of fatty acids to adipose tissue. After LPL activity, the chylomicron remnant is relatively enriched in cholesterol due to the loss of triacylglycerol, and absorbed into the liver by Apo E. The endogenous pathway begins with the synthesis of very LDL (VLDL) particles, which are triglyceride-rich and contain Apo B-100, C-II, and E. After removal of the triglycerides to adipose tissue, a portion of VLDL remnants are metabolized to LDL particles [4] that transport cholesterol esters and lesser amounts of triglycerides. Small LDL particles penetrate the endothelial barrier and deposit in the extracellular matrix of subendothelial spaces by Apo B-100 binding to proteoglycans, which are among the most important molecules for lipoprotein retention [5,6,7]. Retention of LDL particles in the vessel wall is considered the first step in atherosclerosis pathogenesis [8]. 2.2. LDL Modification and Oxidization in Atherosclerosis In the second step of atherosclerosis pathogenesis, subendothelial LDL is oxidized by resident vascular cells, and triggers vascular-cell production of monocyte chemoattractant protein-1 (MCP-1) and macrophage colony stimulating factors (M-CSFs) [9]. Under smoking, hypertension, hyperglycemia, and hyperlipidemia status, the production of reactive oxygen species (ROS) is increased, and overwhelms the endogenous antioxidant response. The oxidative stress increases LDL oxidation and impairs endothelial function [10,11,12]. Chronic oxidative stress is a stronger risk of atherosclerosis formation. In the initial phase of LDL modification, the lipid components are interacted with ROS, and produce many types of lipid oxidation products [13]. The lipid oxidation products, such lysophospholipid products, attack with the Apo B protein. Apo B are oxidized, and lead to changes in the amino acid side chains by breaking peptide bonds. After modification of Apo B, oxidized LDL (ox-LDL) becomes a ligand of scavenger receptors [14]. The retention of ox-LDL is recognized, and interacts with two major scavenger receptors on macrophages: class A scavenger receptors (SR) AI/II, and class B scavenger receptor cluster of differentiation 36 (CD36). The SRAI/II recognizes the modification of Apo B protein on ox-LDL, and oxidized phospholipids are recognized by CD36. After interaction with scavenger receptors, the macrophages are activated and uptake ox-LDL. Ox-LDL also induces several pro-inflammatory conditions via a lectin-like oxidized LDL receptor-1 (LOX-1) [15]. The chemotactic activity from the oxidative modification of LDL stimulates monocyte binding to endothelial cells, thereby increasing the adhesive properties of the endothelium, including the overexpression of intercellular adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1) [16,17,18]. Inflammatory cells and monocytes subsequently release MCP-1 to activate leukocytes in the media and stimulate the proliferation of SMCs. The monocytes differentiate into macrophages with the expression of scavenger receptors (SRs), including SR-AI/II, SR-BI, CD36, LOX-1, and Toll-like receptors (TLRs), and lead to lipid accumulation [19]. Ox-LDL–CD36 interaction induces increased ox-LDL internalization and activates additional macrophages (Figure 1). Recently reported data support ox-LDL participation in not only macrophage activation, but also retention [20,21,22,23,24]. Moreover, macrophages induce inflammation progression via interleukin (IL)-1β, tumor necrosis factor (TNF), reactive oxygen species (ROS), and metalloproteases [25,26]. [Figure: Small low-density lipoproteins (LDLs) penetrate the endothelial barrier and bind to proteoglycans via apolipoprotein B100 to retain in the subendothelial space. LDL is oxidized (ox-LDL) and induces several pro-inflammatory conditions via lectin-like oxidized LDL receptor-1 (LOX-1). The upregulation of intercellular adhesion molecule-1 (ICAM-1) and vascular-cell adhesion molecule-1 (VCAM-1) by ox-LDL increase monocyte and inflammatory cell adhesion on the endothelium. Ox-LDL particles stimulate endothelial cells and smooth muscle cells (SMCs) to secrete monocyte chemotactic protein-1 (MCP-1) and monocyte colony stimulating factor (M-CSF), with both factors inducing monocyte recruitment. Ox-LDL promotes an increased in reactive oxygen species (ROS) and inhibits nitric oxide production. Monocytes differentiate into macrophages and express scavenger receptors (SRs), cluster of differentiation 36 (CD36), LOX-1, and Toll-like receptors (TLRs). Ox-LDL–CD36 interaction induces monocyte differentiation, macrophage activation, and macrophage retention, and macrophage SRs increase ox-LDL uptake and foam-cell formation. The retention of ox-LDL leads to foam cell apoptosis and inflammatory progression. Ox-LDLs also increase the expression of growth factors, including platelet-derived growth factor (PDGF) for migration and basic fibroblast growth factor (bFGF) for proliferation, on SMCs. SMC proliferation contributes to the thickening of atherosclerotic plaques and formation of a necrotic core. The ox-LDL–CD36 interaction in resting platelets causes platelet aggregation and activation, with activated platelets expressing LOX-1 to mediate adhesion to endothelial cells and enhance endothelin-1 release. The endothelial function is impaired along with decreasing nitric oxide production and increasing prostaglandin synthesis.] Ox-LDLs also increase the expression of growth factors, including platelet-derived growth factor for migration and basic fibroblast growth factor, for proliferation on SMCs [27,28,29]. SMC proliferation contributes to the thickening of atherosclerotic plaques and the formation of a necrotic core [30]. Activation of inflammatory cytokines and ox-LDL influence extracellular matrix remodeling and cause lesion thinning by increasing matrix metalloproteinase (MMP)-1 and -9

Read the complete text